RMD

ResMed Inc.
$228.35
-0.84 (-0.37%)
Mkt Cap 33.12B
Volume 837,607
52W Range 180.27-284.87
Sector Healthcare
Beta 0.77
EPS (TTM) 10.44 USD
P/E Ratio 21.87
Revenue (TTM) 5.65B USD
Rev Growth (5Y) +12.1%
EPS Growth (5Y) +26.1%
AlphaVal · Fair Value
What we estimate one share is worth
$200.50
Overvalued weak signal
13.9% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
A
Platform & Compounding FCF
89.7 / 100 composite
A platform business that compounds free cash flow — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue 5.65B 5.15B 4.69B 4.22B 3.58B 3.20B 2.96B 2.61B 2.34B 2.07B 1.84B 1.68B
Net Income 1.52B 1.40B 1.02B 897.56M 779.44M 474.50M 621.67M 404.59M 315.59M 342.28M 352.41M 352.89M
EPS 10.44 9.55 6.94 6.12 5.34 3.27 4.31 2.83 2.21 2.42 2.51 2.51
Free Cash Flow 1.65B 1.66B 1.29B 559.30M 195.11M 619.89M 696.32M 381.71M 433.57M 342.58M 480.10M 311.24M
FCF / Share 11.40 11.33 8.75 3.81 1.34 4.27 4.82 2.67 3.04 2.42 3.42 2.22
Operating CF 1.81B 1.75B 1.40B 693.30M 351.15M 736.72M 802.25M 459.05M 505.03M 414.05M 547.93M 383.18M
Total Assets 8.97B 8.17B 6.87B 6.75B 5.10B 4.73B 4.59B 4.11B 3.06B 3.47B 3.26B 2.18B
Total Debt 825.92M 851.81M 873.93M 1.58B 917.55M 793.72M 1.30B 1.27B 281.45M 1.08B 1.17B 300.59M
Cash & Equiv 1.47B 1.21B 238.36M 227.89M 273.71M 295.28M 463.16M 147.13M 188.70M 821.93M 731.43M 717.25M
Book Value 6.59B 5.97B 4.86B 4.13B 3.36B 2.89B 2.50B 2.07B 2.06B 1.96B 1.69B 1.59B
Return on Equity 0.23 0.23 0.21 0.22 0.23 0.16 0.25 0.20 0.15 0.17 0.21 0.22
RMD News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ResMed Inc. - RMD
Sep 03, 2026 06:00 AM · prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ResMed Inc. - RMD
Sep 01, 2026 02:25 PM · globenewswire.com
Canada Pension Plan Investment Board Buys New Position in ResMed Inc. $RMD
Aug 30, 2026 12:26 AM · defenseworld.net
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ResMed Inc. - RMD
Aug 27, 2026 12:15 PM · prnewswire.com
Resmed Announces Participation in the 24th Annual Morgan Stanley Global Healthcare Conference
Aug 27, 2026 12:05 PM · globenewswire.com
228,458 Shares in ResMed Inc. $RMD Purchased by American Capital Management Inc.
Aug 27, 2026 01:15 AM · defenseworld.net
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ResMed Inc. - RMD
Aug 25, 2026 02:33 PM · globenewswire.com
The IRS Makes You Sell Whether the Market Is Up or Down. These 3 ETFs Fund the RMD Without Touching a Share
Aug 20, 2026 02:15 PM · 247wallst.com
Resmed Announces Appointment of Carol Burt as Lead Director and Planned Retirement of Director Ron Taylor
Aug 17, 2026 12:10 PM · globenewswire.com
87,722 Shares in ResMed Inc. $RMD Purchased by Avalon Trust Co
Aug 15, 2026 11:47 PM · defenseworld.net